# Hyaluronidase Via LADD Scleroderma-induced Microstomia

> **NCT05995626** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Nebraska** · enrollment: 3 (actual)

## Conditions studied

- Microstomia
- Scleroderma

## Interventions

- **DRUG:** Hyaluronidase
- **DEVICE:** CO2 laser

## Key facts

- **NCT ID:** NCT05995626
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-01
- **Primary completion:** 2024-09-24
- **Final completion:** 2024-09-24
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05995626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05995626, "Hyaluronidase Via LADD Scleroderma-induced Microstomia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05995626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*